Multigene panels would deliver greater value if patients with actionable genetic mutations consistently received guided treatments.
Read More
The tests will use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases.
Read More
The findings demonstrated what causes some lung cancer patients to have an intrinsic resistance to the drug osimertinib.
Read More
Individuals identified with VeriStrat poor results had significantly lower overall survival when treated with immune checkpoint inhibitor-based regimens.
Read MoreThe companies’ collaboration underscores the need for proteomic data to enable precision medicine strategies for lung cancer patients.
Read More